S100A9 anticorps (C-Term) (Biotin)

N° du produit ABIN111889

Cet anticorps Souris Monoclonal détecte spécifiquement S100A9 dans FACS, IHC (p) et EIA. Il présente une réactivité avec des échantillons de Humain. Il a été cité dans 2+ publications.

Aperçu rapide pour S100A9 anticorps (C-Term) (Biotin) (ABIN111889)

Antigène: S100A9 (S100 Calcium Binding Protein A9 (S100A9))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp S100A9 est conjugé à/à la Biotin

Application: Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Clone: S32-2

Détail du produit anti-S100A9 anticorps (Biotin)

Épitope: C-Term

Specificité: Monoclonal antibody S32.2 identifies the Ca2+-binding 14 kDa subunit of the inflammatory L-1 protein complex, also called S100A9 or Calgranulin B. It is useful for the characterization of circulating granulocytes or inflammatory infiltrates of the myelo-monocytic lineage which express MRP14 differently depending on the inflammatory status of the disease. S32.2 detects a very distinct epitope on the C-terminal end of MRP14 (different from the S 36.48 epitope). The epitope is stable to 0.1 % glutaraldehyde or formalin fixation, and paraffin embedding. Antigen Distribution Isolated cells: The antigen is found in granulocytes and monocytes. It is absent from all other blood cells. In cultured monocytes, maximum MRP-14 is expressed after 3-4 days. Myeloid leukaemia cells have been found to be positive as well. Tissue Sections: MRP-14 is only found in a distinct subpopulation of inflammatory perivascular infiltrates of the myelo-monocytic lineage. Reports from the literature indicate that macrophages synthesise MRP-14 increasingly during the early stages of inflammation. A high MRP-14 (and low MRP-8) expression by macrophages was also reported in granulomatous diseases such as tuberculosis and sarcoidosis. In non-granulomatous chronic inflammatory diseases such as chronic rheumatoid arthritis MRP-8 and MRP-14 positive cells consist of different subpopulations. During early inflammation endothelial cells are also positive with MRP-8/14 determined by antibody 27E10 (Cat.-No BM4025).Antigen Distribution

Réactivité croisée (Details): Species reactivity (tested):Human: MRP14, Granulocytes, stimulated Monocytes and Macrophages. Does not react with Bovine and Swine spleen.

Purification: Protein A Chromatography

Immunogène: Cultured Human Monocytes. Remarks: The antigen is MRP14, the epitope is suspected in the carboxyterminal portion of the peptide.

Isotype: IgG1

Information d'application

Indications d'application: ELISA. Flow Cytometry. Immunohistochemistry (IHC) on: Frozen sections: 0.25 μg/mL (1/800)Paraffin sections: 2 μg/mL (1/100), no pretreatment for antigen retrieval necessary. Suggested positive control: Human tonsil. Has been described to work Dot blots.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Reconstitution: Restore in 0.5 mL distilled water to make stock solution.

Concentration: 0.2 mg/mL

Buffer: PBS, pH 7.2 with 5 mg/mL BSA as a stabilizer and kathon as a preservative

Agent conservateur: Kathon CG

Précaution d'utilisation: This product contains Kathon CG a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: This product is photosensitive and should be protected from light

Stock: 4 °C

Stockage commentaire: Store the antibody undiluted undiluted at 2-8 °C. DO NOT FREEZE!

Références pour anticorps anti-S100A9 (Biotin) (ABIN111889)

Mortezai, Harder, Schnabel, Moors, Gauly, Schlüter, Wagener, Buck: "Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids." dans: Journal of proteome research, Vol. 9, Issue 12, pp. 6126-34, (2010) (PubMed).

Rosenberger, Thorey, Werner, Boukamp: "A novel regulator of telomerase. S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT." dans: The Journal of biological chemistry, Vol. 282, Issue 9, pp. 6126-35, (2007) (PubMed).

Détails sur S100A9

Antigène: S100A9 (S100 Calcium Binding Protein A9 (S100A9))

Autre désignation: S100A9 / Calgranulin-B / MRP14

Sujet: S100A9 is a member of the S100 family of proteins. S100A9, together with S100A8 forms a heterodimeric protein complex, Calprotectin, which is a major calcium- and zinc-binding protein in the cytosol of neutrophils, monocytes, and keratinocytes. Complexes of S100A8 and S100A9 are the physiologically relevant forms of these proteins. S100A9 may function in the inhibition of casein kinase and altered expression of this protein is associated with the disease cystic fibrosis. Its expression and potential cytokine-like function in inflammation and in cancer suggest that S100A8/A9 may play a key role in inflammation-associated cancer.Synonyms: CAGB, Calprotectin L1H subunit, Leukocyte L1 complex heavy chain, MRP-14, Migration inhibitory factor-related protein 14, S100 calcium-binding protein A9, S100-A9

ID gène: 9606

UniProt: P06702

Pathways: Transition Metal Ion Homeostasis, Positive Regulation of Endopeptidase Activity, S100 Proteins